RE:RE:RE:RE:RE:RE:RE:RE:RE:A 3rd CR at 450 days?Agreed Rumpl see no earthly reason for them not to have dosed the patients at the beginning of Phase II in precisely the same way as they had highly successfully dosed 5 & 6 at the end of Phase IB.
Yes - maybe they did so. Maybe they fluked 5 and 6 and drew (as we all did) the wrong conclusions from this tiny early sample? Maybe they hadn`t established the protocol to optimise the success of the treatment? Maybe they haven`t now??